BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong DI, Madrigal-Burgaleta R, Banerji A, Castells M, Alvarez-Cuesta E. Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel? J Allergy Clin Immunol Pract 2020;8:2907-2915.e1. [PMID: 32805455 DOI: 10.1016/j.jaip.2020.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Madrigal-burgaleta R, Alvarez-cuesta E, Madrigal-burgaleta R, Broyles AD, Cuesta-herranz J, Guzman-melendez MA, Maciag MC, Phillips EJ, Trubiano JA, Wong JT, Ansotegui I, Ali FR, Angel-pereira D, Banerji A, Berges-gimeno MP, Bernal-rubio L, Brockow K, Cardona Villa R, Castells MC, Caubet J, Chang Y, Ensina LF, Chikhladze M, Chiriac AM, Chung W, Ebisawa M, Fernandes B, Garvey LH, Gomez M, Gomez Vera J, Gonzalez Diaz S, Hong DI, Ivancevich JC, Kang H, Khan DA, Kuruvilla M, Larco Sousa JI, Latour-staffeld P, Liu AY, Macy E, Malling HJ, Maspero J, May SM, Mayorga C, Park MA, Peter J, Picard M, Rodriguez-bouza T, Romano A, Tanno LK, Torres MJ, Ureña-tavera A, Valluzzi RL, Volcheck GW, Yamaguchi M. Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement. World Allergy Organization Journal 2022;15:100640. [DOI: 10.1016/j.waojou.2022.100640] [Reference Citation Analysis]
2 Madrigal-Burgaleta R, Vazquez-Revuelta P, Marti-Garrido J, Lleonart-Bellfill R, Ali FR, Alvarez-Cuesta E. Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy. Allergy 2021;76:2636-40. [PMID: 33683735 DOI: 10.1111/all.14810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kim HH, Seo J, Ahn YH, Kim H, Yoon J, Suh JH, Kang DY, Lee SY, Kang H. Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol. Front Allergy 2022;3:786822. [DOI: 10.3389/falgy.2022.786822] [Reference Citation Analysis]
4 Blumenthal KG, Phillips EJ. Positioning Drug Allergy Delabeling as a Critical Tool for Precision Medicine, Quality Improvement, and Public Health. J Allergy Clin Immunol Pract 2020;8:2916-9. [PMID: 32781047 DOI: 10.1016/j.jaip.2020.07.046] [Reference Citation Analysis]
5 Madrigal-burgaleta R, Guzman-melendez MA, Alvarez-cuesta E. New Technical Aspects Used in the Management of Desensitization to Antineoplastic Drugs. Curr Treat Options Allergy. [DOI: 10.1007/s40521-022-00312-7] [Reference Citation Analysis]
6 Madrigal-Burgaleta R, Guzman-Melendez MA, Alvarez-Cuesta E. Drug allergy desensitization is not a unique recipe. Curr Opin Allergy Clin Immunol 2022;22:167-74. [PMID: 35152228 DOI: 10.1097/ACI.0000000000000821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tsao LR, Young FD, Otani IM, Castells MC. Hypersensitivity Reactions to Platinum Agents and Taxanes. Clin Rev Allergy Immunol 2021. [PMID: 34338975 DOI: 10.1007/s12016-021-08877-y] [Reference Citation Analysis]
8 Bavbek S, Pagani M, Alvarez-Cuesta E, Castells M, Dursun AB, Hamadi S, Madrigal-Burgaleta R, Sanchez-Sanchez S, Vultaggio A. Hypersensitivity reactions to biologicals: An EAACI position paper. Allergy 2022;77:39-54. [PMID: 34157134 DOI: 10.1111/all.14984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Pagani M, Bavbek S, Alvarez-Cuesta E, Berna Dursun A, Bonadonna P, Castells M, Cernadas J, Chiriac A, Sahar H, Madrigal-Burgaleta R, Sanchez Sanchez S. Hypersensitivity reactions to chemotherapy: an EAACI Position Paper. Allergy 2022;77:388-403. [PMID: 34587281 DOI: 10.1111/all.15113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Labella M, Castells M. Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization. Ann Allergy Asthma Immunol 2021;126:623-9. [PMID: 33781937 DOI: 10.1016/j.anai.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vega A, Peña MI, Torrado I. Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies. Front Allergy 2022;2:786863. [DOI: 10.3389/falgy.2021.786863] [Reference Citation Analysis]
12 Sala-Cunill A, Molina-Molina GJ, Verdesoto JT, Labrador-Horrillo M, Luengo O, Galvan-Blasco P, Guilarte M, Cardona V. One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year Experience. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00712-1. [PMID: 34214705 DOI: 10.1016/j.jaip.2021.06.024] [Reference Citation Analysis]
13 Gorgulu Akin B, Erkoc M, Korkmaz ET, Ozdel Ozturk B, Colak S, Ozalp Ates FS, Bavbek S. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions. World Allergy Organ J 2022;15:100619. [PMID: 34992710 DOI: 10.1016/j.waojou.2021.100619] [Reference Citation Analysis]